The approval of novel orphan drug designations continues to grow, while many existing rare disease therapies are receiving approval for expanded indications.…

Pfizer

Pfizer looks at building major gene therapy manufacturing facility in North Carolina

GSK's vaccines access leads the pack, report says, as lagging Pfizer disputes findings